ATE511651T1 - Transglutaminase 6 als diagnostischer indikator für autoimmunerkrankungen - Google Patents
Transglutaminase 6 als diagnostischer indikator für autoimmunerkrankungenInfo
- Publication number
- ATE511651T1 ATE511651T1 AT07007262T AT07007262T ATE511651T1 AT E511651 T1 ATE511651 T1 AT E511651T1 AT 07007262 T AT07007262 T AT 07007262T AT 07007262 T AT07007262 T AT 07007262T AT E511651 T1 ATE511651 T1 AT E511651T1
- Authority
- AT
- Austria
- Prior art keywords
- transglutaminase
- autoimmune diseases
- diagnostic indicator
- novel antigen
- diagnostic
- Prior art date
Links
- 101000666174 Homo sapiens Protein-glutamine gamma-glutamyltransferase 6 Proteins 0.000 title abstract 2
- 102100038112 Protein-glutamine gamma-glutamyltransferase 6 Human genes 0.000 title abstract 2
- 208000023275 Autoimmune disease Diseases 0.000 title 1
- 239000000427 antigen Substances 0.000 abstract 2
- 102000036639 antigens Human genes 0.000 abstract 2
- 108091007433 antigens Proteins 0.000 abstract 2
- 230000006472 autoimmune response Effects 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 230000004064 dysfunction Effects 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1025—Acyltransferases (2.3)
- C12N9/104—Aminoacyltransferases (2.3.2)
- C12N9/1044—Protein-glutamine gamma-glutamyltransferase (2.3.2.13), i.e. transglutaminase or factor XIII
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/91—Transferases (2.)
- G01N2333/91045—Acyltransferases (2.3)
- G01N2333/91074—Aminoacyltransferases (general) (2.3.2)
- G01N2333/9108—Aminoacyltransferases (general) (2.3.2) with definite EC number (2.3.2.-)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/06—Gastro-intestinal diseases
- G01N2800/065—Bowel diseases, e.g. Crohn, ulcerative colitis, IBS
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/24—Immunology or allergic disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07007262A EP1978364B1 (de) | 2007-04-06 | 2007-04-06 | Transglutaminase 6 als diagnostischer Indikator für Autoimmunerkrankungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE511651T1 true ATE511651T1 (de) | 2011-06-15 |
Family
ID=38158045
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT07007262T ATE511651T1 (de) | 2007-04-06 | 2007-04-06 | Transglutaminase 6 als diagnostischer indikator für autoimmunerkrankungen |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20130196336A1 (de) |
| EP (1) | EP1978364B1 (de) |
| AT (1) | ATE511651T1 (de) |
| AU (1) | AU2008234999A1 (de) |
| CA (1) | CA2683394A1 (de) |
| RU (1) | RU2009140980A (de) |
| WO (1) | WO2008122432A1 (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU0900195D0 (en) * | 2009-04-01 | 2009-06-29 | Debreceni Egyetem | Diagnosis and treatment of gluten-induced autoimmune diseases |
| HU0900199D0 (en) * | 2009-04-01 | 2009-06-29 | Debreceni Egyetem | Diagnosis of gluten-induced autoimmune diseases |
| EP2322926A1 (de) * | 2009-11-11 | 2011-05-18 | Zedira GmbH | Stabilisiertes Transglutaminase als diagnostischer Indikator für Autoimmunerkrankungen |
| EP2462439B1 (de) | 2009-11-11 | 2016-08-10 | Zedira GmbH | Stabilisiertes Transglutaminase als diagnostischer Indikator für Autoimmunerkrankungen |
| WO2011142901A1 (en) | 2010-05-13 | 2011-11-17 | University Of Medicine And Dentistry Of New Jersey | Diagnostic biomarker profiles for the detection and diagnosis of alzheimer's disease |
| CN102220337B (zh) * | 2010-09-19 | 2012-11-14 | 中南大学 | 一种遗传性脊髓小脑共济失调相关基因 |
| RU2441240C1 (ru) * | 2010-10-05 | 2012-01-27 | Государственное образовательное учреждение высшего профессионального образования "Московский государственный медико-стоматологический университет" Министерства здравоохранения и социального развития Российской Федерации | Способ диагностики аксонально-демиелинизирующих полиневропатий |
| AU2012207267C1 (en) * | 2011-01-20 | 2017-11-23 | Cyrex Laboratories, Llc | Methods and apparatus for detection of gluten sensitivity, and its differentiation from celiac disease |
| WO2013010003A1 (en) | 2011-07-12 | 2013-01-17 | University Of Medicine And Dentistry Of New Jersey | Diagnostic biomarker profiles for the detection and diagnosis of alzheimer's disease |
| CN107525919B (zh) * | 2016-06-21 | 2023-03-28 | 欧蒙医学实验诊断股份公司 | 诊断共孵育测定法 |
| IT202100019616A1 (it) * | 2021-07-23 | 2023-01-23 | Univ Degli Studi Di Trieste | Nuovo metodo |
| CN116515786B (zh) * | 2023-04-26 | 2024-05-28 | 广东医科大学 | 一种人tgm3乙酰化多肽、抗原、抗体及其制备方法和应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19630557C2 (de) | 1996-07-18 | 1998-07-02 | Schuppan Detlef Priv Doz Dr Dr | Verfahren zum Nachweis von Antikörpern aus Körperflüssigkeiten durch eine Immunreaktion mit Gewebe-Transglutaminase (tTG) sowie die Verwendung von tTG in Diagnose und Therapie |
| WO2001001133A2 (en) | 1999-06-28 | 2001-01-04 | Immundiagnostik Ag | Diagnosis of gluten sensitive enteropathy and other autoimmunopathies |
| EP1317548B1 (de) | 2000-09-15 | 2009-11-18 | Zedira GmbH | Transglutaminase genprodukte |
| GB0103024D0 (en) * | 2001-02-07 | 2001-03-21 | Rsr Ltd | Assay for Autoantibodies to tissue transglutaminase |
-
2007
- 2007-04-06 AT AT07007262T patent/ATE511651T1/de not_active IP Right Cessation
- 2007-04-06 EP EP07007262A patent/EP1978364B1/de active Active
-
2008
- 2008-04-07 US US12/594,926 patent/US20130196336A1/en not_active Abandoned
- 2008-04-07 AU AU2008234999A patent/AU2008234999A1/en not_active Abandoned
- 2008-04-07 CA CA002683394A patent/CA2683394A1/en not_active Abandoned
- 2008-04-07 RU RU2009140980/15A patent/RU2009140980A/ru not_active Application Discontinuation
- 2008-04-07 WO PCT/EP2008/002744 patent/WO2008122432A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| RU2009140980A (ru) | 2011-05-20 |
| AU2008234999A1 (en) | 2008-10-16 |
| EP1978364B1 (de) | 2011-06-01 |
| CA2683394A1 (en) | 2008-10-16 |
| US20130196336A1 (en) | 2013-08-01 |
| WO2008122432A1 (en) | 2008-10-16 |
| EP1978364A1 (de) | 2008-10-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE511651T1 (de) | Transglutaminase 6 als diagnostischer indikator für autoimmunerkrankungen | |
| EA201100231A1 (ru) | Диагностический анализ на основе антител | |
| WO2007117444A3 (en) | Protein detection by aptamers | |
| WO2012122374A3 (en) | Non-invasive methods for diagnosing chronic organ transplant rejection | |
| DK1974210T3 (da) | Fremgangsmåde til diagnosticering af polycystisk nyresygdom | |
| EP2539712A1 (de) | Verfahren und zusammensetzungen zur diagnose und prognose von nierenverletzungen und niereninsuffizienz | |
| DE602006007703D1 (de) | Verbesserte immuntestverfahren | |
| CA2839777C (en) | Methods for the prognostic and/or diagnostic of neurodegenerative disease, methods to identify candidate compounds and compounds for treating neurodegenerative disease | |
| DE602006011896D1 (de) | Diagnoseverfahren für erkrankungen im zusammenhang mit hirnschäden | |
| EA201390150A1 (ru) | Способы выявления сигнатур заболевания или патологических состояний в текучих средах организма | |
| NO20093327L (no) | Biomarkorer for multippel sklerose | |
| WO2008148072A3 (en) | Disease-associated genetic variations and methods for obtaining and using same | |
| EA201001874A1 (ru) | Способ диагностики злокачественных новообразований, экспрессирующих рецептор her2 или его укороченные варианты | |
| DK1831699T3 (da) | Bestemmelse af neutrofil gelatine-associeret lipocalin (NGAL) som en diagnostisk markør for nyresygdomme | |
| EP2757160A3 (de) | Genexpressionsmarker für Morbus Crohn | |
| NO20070949L (no) | Transkriptomdiagnostikk i spytt | |
| CY1123265T1 (el) | Μια αναλυση κυτταρικως μεσολαβουμενης ανοσοαποκρισhς | |
| WO2009083950A3 (en) | Biomarkers for the prediction of renal injury | |
| ATE471512T1 (de) | Verwendung des proteins s100a 12 als marker für kolorektalkarzinom | |
| WO2006134390A3 (en) | Method for diagnosing neurodegenerative disease | |
| AR054479A1 (es) | Metodo para diagnosticar l a enfermedad de alzheimer | |
| BR112015014232A2 (pt) | lesão renal aguda | |
| WO2007119111A3 (en) | Tissue diagnostics for ovarian cancer | |
| MX339765B (es) | Metodos y composiciones para diagnostico y pronostico de lesion renal y falla renal. | |
| WO2011109112A3 (en) | Method of detecting tau protein and tau fragments in serum |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |